SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001818382-24-000049
Filing Date
2024-04-29
Accepted
2024-04-29 07:16:47
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A huma-2024defa14a.htm DEFA14A 9346
2 noticecard_pagex1.jpg GRAPHIC 90939
3 noticecard_pagex2.jpg GRAPHIC 60888
  Complete submission text file 0001818382-24-000049.txt   218472
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39532 | Film No.: 24886583
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)